Showing results (11-20 of 51) with videos related to
Sort By:
Pageof 6
JAMA|June 24, 2010
Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variationBrady L Stein, Alison R MoliternoJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 11, 2013
Biological rationale and clinical use of interferon in the classical BCR-ABL-negative myeloproliferative neoplasmsBrady L Stein, Ramon V TiuHematology. American Society of Hematology. Education Program|December 4, 2016
Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisionsJamile M Shammo, Brady L SteinCancer Treatment and Research|July 19, 2019
Thrombosis in the Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsKamya Sankar, Brady L Stein, Raajit K RampalCurrent Opinion in Oncology|October 14, 2011
Janus kinase inhibitors: an update on the progress and promise of targeted therapy in the myeloproliferative neoplasmsBrady L Stein, John D Crispino, Alison R MoliternoAnnals of Hematology|October 2, 2014
Polycythemia vera disease burden: contributing factors, impact on quality of life, and emerging treatment optionsBrady L Stein, Alison R Moliterno, Ramón V TiuLeukemia Research Reports|December 28, 2013
Complex hypereosinophilia arising from post-polycythemia vera myelofibrosis: A case of imatinib-responsivenessRyan D Gentzler, Alex C Minella, Brady L SteinThrombosis|November 16, 2011
Gender and Vascular Complications in the JAK2 V617F-Positive Myeloproliferative NeoplasmsBrady L Stein, Alfred Rademaker, Jerry L Spivak, et al.The Journal of Molecular Diagnostics : JMD|March 6, 2010
Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencingTodd S Laughlin, Alison R Moliterno, Brady L Stein, et al.Leukemia & Lymphoma|April 11, 2015
Novel therapies for myelofibrosisBrady L Stein, Francisco Cervantes, Francis Giles, et al.Pageof 6